CRISPR Therapeutics (CRSP) Q3 2025 Earnings

4AugConfirmed
Q4 2024
Q1 2025
Q2 2025
Q3 2025
-2.4
-1.75
-1.09
-0.44

Details

Expected EPS
-1.401529
Actual EPS
-2.4
Surprise EPS
-1
Surprise Percent
+71.24%

Description

CRISPR Therapeutics (CRSP) has reported earnings of -2.4 per share for Q3 2025.

0 Comments

Share your thoughts